RESEARCH UPDATE

NBTS Launches DNA Damage Response Consortium

National Brain Tumor Society recently launched our new flagship research initiative called the DNA Damage Response Consortium in partnership with Yale Cancer Center. This collaboration of renowned adult and pediatric researchers will look at how treatments could target a brain tumor’s DNA damage response network. Learn more about how this consortium may propel a new class of treatments forward for both adults and children with different types of malignant brain tumors.

LEARN MORE

TAKE ACTION

Register Now for Head to the Hill on May 2-3

Icon of two hands shaking and creating a heart.

Join NBTS and fellow advocates for Head to the Hill on May 2-3, 2022. Share your story and urge policymakers to address the critical issues affecting the brain tumor community. Whether you choose to attend live training sessions and social events in person or participate entirely from your own home, you’ll be helping to take the next step in defeating brain tumors—once and for all.

LEARN MORE

CARE FOR THE COMMUNITY

Access Key Resources To Navigate Your Brain Tumor Experience

NBTS provides comprehensive resources to equip brain tumor patients and their loved ones. Our Informed in 30 video series will help you unlock complex brain tumor concepts in four new installments this year. The NBTS Clinical Trial Finder is an easy way to search for local trial treatment options specific to your tumor type. You can find these resources along with key questions to ask your health care team and so much more in the Brain Tumor Experience of our website.